Skip to main content
Log in

Drug-Related Problems in Hospitalised Patients

  • Review Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Drug-related problems include medication errors (involving an error in the process of prescribing, dispensing, or administering a drug, whether there are adverse consequences or not) and adverse drug reactions (any response to a drug which is noxious and unintended, and which occurs at doses normally used in humans for prophylaxis, diagnosis or therapy of disease, or for the modification of physiological function). Furthermore, adverse drug events can be defined as an injury — whether or not causally-related to the use of a drug.

Drug-related problems are relatively common in hospitalised patients and can result in patient morbidity and mortality, and increased costs. In order to get an overview of studies on drug-related problems in hospitalised patients, with specific attention to the incidence of drug-related problems and their costs, to the possibilities of prevention and to the effect of these interventions, we performed a literature search.

Incidences of medication errors reported in studies vary widely. The range of reported incidences of adverse drug reactions is even wider. These wide ranges can be largely explained by the different study methods and definitions used.

Problems related to drug therapy may be averted by preventive interventions. Several possibilities for prevention exist, especially for the prevention of medication errors. Prescribing, transcription and interpretation errors can be reduced by using computerised physician order entry. Together with the use of automated dispensing systems and bar-code technology, this will aid in the reduction of both dispensing and administration errors. Education of nursing staff involved in the process of drug distribution is another important measure for preventing medication errors. Finally, the introduction of systems for the early detection of adverse drug reactions may help to reduce problems related to drug therapy. Identifying risk factors that contribute to the development of adverse drug reactions, may aid in the prevention of these reactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1
Table II
Table III
Table IV

Similar content being viewed by others

References

  1. Meyboom RHB, Egberts ACG, Edwards R, et al. Principles of signal detection in pharmacovigilance. Drug Saf 1997; 16: 355–65

    Article  PubMed  CAS  Google Scholar 

  2. Phillips DP, Christenfeld N, Glynn LM. Increase in US medication-error deaths between 1983 and 1993. Lancet 1998; 351: 643–4

    Article  PubMed  CAS  Google Scholar 

  3. Bates DW. Drugs and adverse drug reactions: how worried should we be? JAMA 1998; 279: 1216–7

    Article  PubMed  CAS  Google Scholar 

  4. Johnson JA, Bootman JL. Drug-related morbidity and mortality — a cost-of-illness model. Arch Intern Med 1995; 155: 1949–56

    Article  PubMed  CAS  Google Scholar 

  5. Pirmohamed M, Breckenridge AM, Kitteringham NR, et al. Adverse drug reactions. BMJ 1998; 316: 1295–8

    Article  PubMed  CAS  Google Scholar 

  6. Leape LL. Preventing adverse drug events. Am J Health Syst Pharm 1995; 52: 379–82

    PubMed  CAS  Google Scholar 

  7. Anonymus. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health Syst Pharm 1995; 52:417–9

  8. Bradbury K, Wang J, Haskins G, et al. Prevention of medication errors. Developing a continuous-quality-improvement approach. Mt Sinai J Med 1993; 60: 379–86

    PubMed  CAS  Google Scholar 

  9. Vitillo J, Lesar TS. Preventing medication prescribing errors. DICP 1991; 25: 1388–94

    PubMed  CAS  Google Scholar 

  10. Dean BS, Allan EL, Barber ND, et al. Comparison of medication errors in an American and a British hospital. Am J Health Syst Pharm 1995; 52: 2543–9

    PubMed  CAS  Google Scholar 

  11. Taxis K, Dean B, Barber N. Hospital drug distribution systems in the UK and Germany - a study of medication errors. Pharm World Sci 1999; 21: 25–31

    Article  PubMed  CAS  Google Scholar 

  12. McNally KM, Sunderland VB. No-blame medication administration error reporting by nursing staff at a teaching hospital in Australia. Int J Pharm Pract 1998; 6: 67–71

    Article  Google Scholar 

  13. Schneider MP, Cotting J, Pannatier A. Evaluation of nurses’ errors associated in the preparation and administration of medication in a pediatric intensive care unit. Pharm World Sci 1998; 20: 178–82

    Article  PubMed  CAS  Google Scholar 

  14. Tissot E, Cornette C, Demoly P, et al. Medication errors at the administration stage in an intensive care unit. Intensive Care Med 1999; 25: 353–9

    Article  PubMed  CAS  Google Scholar 

  15. Shaughnessy AF, D’Amico F. Long-term experience with a program to improve prescription-writing skills. Fam Med 1994; 26: 168–71

    PubMed  CAS  Google Scholar 

  16. Schumock GT, Guenette AJ, Keys TW, et al. Prescribing errors for patients about to be discharged from a university teaching hospital. Am J Hosp Pharm 1994; 51: 2288–90

    PubMed  CAS  Google Scholar 

  17. Lesar TS, Lomaestro BM, Pohl H. Medication-prescribing errors in a teaching hospital. Arch Intern Med 1997; 157: 1569–76

    Article  PubMed  CAS  Google Scholar 

  18. Bates DW, Boyle DL, Vander Vliet MB, et al. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995; 10: 199–205

    Article  PubMed  CAS  Google Scholar 

  19. Hartwig SC, Denger SD, Schneider PJ. Severity-indexed, incident report-based medication error-reporting program. Am J Hosp Pharm 1991; 48: 2611–6

    PubMed  CAS  Google Scholar 

  20. Lacasa C, Cot R, Roure C, et al. Medication errors in a general hospital. Eur Hosp Pharm 1998; 4: 35–40

    Google Scholar 

  21. Schumock GT, Thornton JP, Witte KW. Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions. Am J Hosp Pharm 1991; 48: 1974–6

    PubMed  CAS  Google Scholar 

  22. Classen DC, Pestotnik SL, Evans RS, et al. Description of a computerized adverse drug event monitor using a hospital information system. Hosp Pharm 1992; 27(9): 774, 776-9, 783

    PubMed  CAS  Google Scholar 

  23. Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991; 266: 2847–51

    Article  PubMed  CAS  Google Scholar 

  24. Lindley CM, Tully MP, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294–300

    Article  PubMed  CAS  Google Scholar 

  25. Wodtke JM, Generali JA. Use of medical record codes to identify adverse drug reactions. Am J Hosp Pharm 1993; 50: 1915–6

    PubMed  CAS  Google Scholar 

  26. Madsen JJ. Comparison of concurrent and retrospective methods of detecting adverse drug reactions. Am J Hosp Pharm 1993; 50: 2556–7

    PubMed  CAS  Google Scholar 

  27. van Kraaij DJW, Haagsma CJ, Go IH, et al. Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. Neth J Med 1994; 44: 166–73

    Article  PubMed  Google Scholar 

  28. Nazario M, Feliu JF, Rivera GC. Adverse drug reactions: The San Juan Department of Veterans Affairs Medical Center experience. Hosp Pharm 1994; 29: 244–46, 249-50

    PubMed  CAS  Google Scholar 

  29. Chan TYK, Critchley JAJH. Reporting of adverse drug reactions in relation to general medical admissions to a teaching hospital in Hong Kong. Pharmacoepidemiol Drug Saf 1994; 3: 85–9

    Article  Google Scholar 

  30. Bowman L, Carlstedt BC, Black CD. Incidence of adverse drug reactions in adult medical inpatients. Can J Hosp Pharm 1994; 47: 209–16

    PubMed  CAS  Google Scholar 

  31. Pearson TF, Pittman DG, Longley JM, et al. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 1994; 51: 2268–72

    PubMed  CAS  Google Scholar 

  32. Vandel P, Bizouard P, Vandel S, et al. Undesirable effects of drugs: epidemiologic study at a psychiatric service of a university hospital [in french]. Therapie 1995; 50: 67–72

    PubMed  CAS  Google Scholar 

  33. Johnstone DM, Kirking DM, Vinson BE. Comparison of adverse drug reactions detected by pharmacy and medical records departments. Am J Health Syst Pharm 1995; 52: 297–301

    PubMed  CAS  Google Scholar 

  34. Sacilotto K, Bagheri H, Lapeyre-Mestre M, et al. Adverse drug effect notifications by nurses and comparison with cases reported by physicians [in French]. Therapie 1995; 50: 455–8

    PubMed  CAS  Google Scholar 

  35. Hall M, McCormack P, Arthurs N, et al. The spontaneous reporting of adverse drug reactions by nurses. Br J Clin Pharmacol 1995; 40: 173–5

    Article  PubMed  CAS  Google Scholar 

  36. Orsini MJ, Orsini PAF, Thorn DB, et al. An ADR surveillance program: increasing quality, number of incidence reports. Formulary 1995; 30: 454–61

    PubMed  CAS  Google Scholar 

  37. Cosentino M, Leoni O, Rispoli L, et al. A 1-year study of drug prescriptions and adverse drug reactions in psychiatric hospital practice. Pharmacoepidemiol Drug Saf 1996; 5: 377–84

    Article  PubMed  CAS  Google Scholar 

  38. Lin Wu F, Yang C, Shen L, et al. Adverse drug reactions in a medical ward. J Formos Med Assoc 1996; 95: 241–6

    Google Scholar 

  39. Smith CC, Bennett PM, Pearce HM, et al. Adverse drug reaction in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996; 42: 423–9

    Article  PubMed  CAS  Google Scholar 

  40. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. JAMA 1997; 277: 301–6

    Article  PubMed  CAS  Google Scholar 

  41. Vargas E, Navarro MI, Laredo L, et al. Effect of drug interactions on the development of adverse drug reactions. Clin Drug Invest 1997; 13: 282–9

    Article  CAS  Google Scholar 

  42. Lee A, Bateman N, Edwards C, et al. Reporting of adverse drug reactions by hospital pharmacists: pilot scheme. BMJ 1997; 315: 519

    Article  PubMed  CAS  Google Scholar 

  43. Moore N, Lecointre D, Noblet C, et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45: 301–8

    Article  PubMed  CAS  Google Scholar 

  44. Azaz-Livshits T, Levy M, Sadan B, et al. Computerized surveillance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol 1998; 45: 309–14

    Article  PubMed  CAS  Google Scholar 

  45. Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999; 33: 236–40

    Article  PubMed  CAS  Google Scholar 

  46. Van den Bemt PMLA, Egberts ACG, Lenderink AW, et al. Adverse drug events in hospitalized patients: a comparison of doctors, nurses and patients as sources of reports. Eur J Clin Pharmacol 1999; 55: 155–8

    Article  PubMed  Google Scholar 

  47. Holland EG, Degruy FV. Drug-induced disorders. Am Fam Physician 1997; 56: 1781–8

    PubMed  CAS  Google Scholar 

  48. Seeger JD, Schumock GT, Xiaodong Kong S. Estimating the rate of adverse drug reactions with capture-recapture analysis.Am J Health Syst Pharm 1996; 53: 178–81

    PubMed  CAS  Google Scholar 

  49. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5

    Article  PubMed  CAS  Google Scholar 

  50. Tully MP, Tallis RC. Inappropriate prescribing and adverse drug reactions in patients admitted to an elderly care unit. J Geriatr Drug Ther 1991; 6: 63–74

    Google Scholar 

  51. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I. N Engl J Med 1991; 370–6

    Google Scholar 

  52. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377–84

    Article  PubMed  CAS  Google Scholar 

  53. Leape LL, Lawthers AG, Brennan TA, et al. Preventing medical injury. Qual Rev Bull 1993; 19: 144–9

    CAS  Google Scholar 

  54. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 1993; 8: 289–94

    Article  PubMed  CAS  Google Scholar 

  55. Cullen DJ, Bates DW, Small SD, et al. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 1995; 21: 541–8

    PubMed  CAS  Google Scholar 

  56. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995; 274: 29–34

    Article  PubMed  CAS  Google Scholar 

  57. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA 1995; 274: 35–43

    Article  PubMed  CAS  Google Scholar 

  58. Cullen DJ, Sweitzer BJ, Bates DW, et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 1997; 25: 1289–97

    Article  PubMed  CAS  Google Scholar 

  59. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. JAMA 1997; 277: 307–11

    Article  PubMed  CAS  Google Scholar 

  60. Vargas E, Simon J, Martin J-C, et al. Effect of adverse drug reactions on length of stay in intensive care units. Clin Drug Invest 1998; 15: 353–60

    Article  CAS  Google Scholar 

  61. Schneider PJ, Gift MG, Lee YP, et al. Cost of medication related problems at a university hospital. Am J Health Syst Pharm 1995; 52: 2415–8

    PubMed  CAS  Google Scholar 

  62. Seeger JD, Xiaodong Kong S, Schumock GT. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients. Pharmacotherapy 1998; 18: 1284–9

    PubMed  CAS  Google Scholar 

  63. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA 1997; 277: 312–7

    Article  PubMed  CAS  Google Scholar 

  64. Cohen MR, Senders J, Davis NM. Failure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidents. Hosp Pharm 1994; 29: 319–30

    PubMed  CAS  Google Scholar 

  65. Petersen LA, Brennan TA, O’Neil AC, et al. Does housestaff discontinuity of care increase the risk for preventable adverse effects? Ann Intern Med 1994; 121: 866–72

    PubMed  CAS  Google Scholar 

  66. Leape LL. Error in medicine. JAMA 1994; 272: 1851–7

    Article  PubMed  CAS  Google Scholar 

  67. Lesar TS. Errors in the use of medication dosage equations. Arch Pediatr Adolesc Med 1998; 152: 340–4

    PubMed  CAS  Google Scholar 

  68. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992; 49: 2229–32

    PubMed  CAS  Google Scholar 

  69. Evans RS, Pestotnik SL, Classen DC, et al. Preventing adverse drug events in hospitalized patients. Ann Pharmacother 1994; 28: 523–7

    PubMed  CAS  Google Scholar 

  70. Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events. JAMA 1998; 280: 1317–20

    Article  PubMed  CAS  Google Scholar 

  71. Anderson JG, Jay SJ, Anderson M, et al. Evaluating the potential effectiveness of using computerized information systems to prevent adverse drug events. Proc AMIA Annu Fall Symp 1997: 228–32

    Google Scholar 

  72. Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311–6

    Article  PubMed  CAS  Google Scholar 

  73. Bates DW, Teich JM, Lee J et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999; 6: 313–21

    Article  PubMed  CAS  Google Scholar 

  74. Leape LL, Cullen DJ, Dempsey Clapp M, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282: 267–70

    Article  PubMed  CAS  Google Scholar 

  75. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacist staffing and drug costs in United States hospitals. Pharmacotherapy 1999; 19: 1354–62

    Article  PubMed  CAS  Google Scholar 

  76. West DW, Levine S, Magram G, et al. Pediatric medication order error rates related to the mode of order transmission. Arch Pediatr Adolesc Med 1994; 148: 1322–6

    Article  PubMed  CAS  Google Scholar 

  77. Attilio RM. Caring enough to understand: the road to oncology medication error prevention. Hosp Pharm 1996; 31: 17–26

    Google Scholar 

  78. Robertson WO. Errors in prescribing. Am J Health Syst Pharm 1995; 52: 382–5

    PubMed  CAS  Google Scholar 

  79. Kelly WN. Pharmacy contributions to adverse medication events. Am J Health Syst Pharm 1995; 52: 385–90

    PubMed  CAS  Google Scholar 

  80. Anonymus. Top-priority actions for preventing adverse drug events in hospitals: recommendations of an expert panel. Am J Health Syst Pharm 1996; 53: 747–51

  81. Klein EG, Santora JA, Pascale PM, et al. Medication cart-filling time, accuracy, and cost with an automated dispensing system. Am J Hosp Pharm 1994; 51: 1193–6

    PubMed  CAS  Google Scholar 

  82. Pepper GA. Errors in drug administration by nurses. Am J Health Syst Pharm 1995; 52: 390–5

    PubMed  CAS  Google Scholar 

  83. D’Arcy PF. Adverse drug reactions in hospital and in the community. Adverse Drug React Toxicol Rev 1997; 16: 95–101

    PubMed  Google Scholar 

  84. Park BK, Pirmohamed M, Kitteringham NR. Idiosyncratic drug reactions: a mechanistic evaluation of risk factors. Br J Clin Pharmacol 1992; 34: 377–95

    Article  PubMed  CAS  Google Scholar 

  85. Carbonin P, Pahor M, Bernabei R, et al. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991; 39: 1093–9

    PubMed  CAS  Google Scholar 

  86. Atkin PA, Shenfield GM. Medication-related adverse reactions and the elderly: a literature review. Adverse Drug React Toxicol Rev 1995; 14: 175–91

    PubMed  CAS  Google Scholar 

  87. Kando JC, Yonkers KA, Cole JO. Gender as a risk factor for adverse events to medications. Drugs 1995; 50: 1–6

    Article  PubMed  CAS  Google Scholar 

  88. Tran C, Knowles SR, Liu BA, et al. Gender differences in adverse drug reactions. J Clin Pharmacol 1998; 38: 1003–9

    Article  PubMed  CAS  Google Scholar 

  89. Bates DW, Miller EB, Cullen DJ et al. Patient risk factors for adverse drug reactions in hospitalized patients. Arch Intern Med 1999; 159: 2553–60

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patricia M.L.A. van den Bemt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van den Bemt, P.M., Egberts, T.C., de Jong-van den Berg, L.T. et al. Drug-Related Problems in Hospitalised Patients. Drug-Safety 22, 321–333 (2000). https://doi.org/10.2165/00002018-200022040-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200022040-00005

Keywords

Navigation